Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg

被引:46
作者
Li, Jingen [1 ,2 ]
Somers, Virend K. [2 ]
Gao, Xiang [3 ]
Chen, Zhuo [4 ]
Ju, Jianqing [4 ]
Lin, Qian [4 ]
Mohamed, Essa A. [2 ]
Karim, Shahid [2 ]
Xu, Hao [4 ]
Zhang, Lijing [1 ]
机构
[1] Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Cardiol, 5 Haiyuncang Hutong, Beijing 100700, Peoples R China
[2] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA
[3] Tieying Hosp Fengtai Dist, Internal Med Div, Beijing, Peoples R China
[4] China Acad Chinese Med Sci, Xiyuan Hosp, Cardiovasc Dis Ctr, Natl Clin Res Ctr Chinese Med Cardiol, XiYuan CaoChang 1, Beijing 100091, Peoples R China
基金
中国国家自然科学基金;
关键词
J-CURVE; HYPERTENSION; TARGETS; EVENTS; TRIAL;
D O I
10.1001/jamanetworkopen.2020.37554
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Extremely low diastolic blood pressure has been reported to be associated with increased adverse cardiovascular events (ie, the diastolic J-shape phenomenon); however, current US guidelines recommend an intensive blood pressure target of less than 130/80 mm Hg without mentioning the lower limits of diastolic blood pressure. OBJECTIVES To evaluate whether there is a diastolic J-shape phenomenon for patients with an treated systolic blood pressure of less than 130 mm Hg and to explore the safe and optimal diastolic blood pressure ranges for this patient population. DESIGN, SETTING, AND PARTICIPANTS This cohort study analyzed outcome data of patients at high cardiovascular risk who were randomized to intensive or standard blood pressure control and achieved treated systolic blood pressure of less than 130 mm Hg in the Systolic Blood Pressure Intervention Trial (SPRINT) and Action to Control Cardiovascular Risk in Diabetes-Blood Pressure (ACCORD-BP) trial. Data were collected from October 2010 to August 2015 (SPRINT) and from September 1999 to June 2009 (ACCORD-BP). Data were analyzed from January to May 2020. EXPOSURE Treated diastolic blood pressure, divided in intervals of less than 60, 60 to less than 70, 70 to less than 80, and 80 mm Hg and greater. MAIN OUTCOMES AND MEASURES The primary outcome was a composite of all-cause death, nonfatal myocardial infarction, and nonfatal stroke. A composite cardiovascular outcome, including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke, was among the key secondary outcomes. RESULTS A total of 7515 patients (mean [SD] age, 65.6 [8.7] years; 4553 [60.6%] men) were included in this analysis. The nominally lowest risk was observed at a diastolic blood pressure between 70 and 80 mm Hg for the primary outcome, the composite cardiovascular outcome, nonfatal myocardial infarction, and cardiovascular death. A mean diastolic blood pressure of less than 60 mm Hg was associated with significantly increased risk of the primary outcome (hazard ratio [HR], 1.46; 95% CI, 1.13-1.90; P = .004), the composite cardiovascular outcome (HR, 1.74; 95% CI, 1.26-2.41; P = .001), nonfatal myocardial infarction (HR, 1.73; 95% CI, 1.15-2.59; P = .008), and nonfatal stroke (HR, 2.67; 95% CI, 1.26-5.63; P = .01). CONCLUSIONS AND RELEVANCE This cohort study found that lowering diastolic blood pressure to less than 60 mm Hg was associated with increased risk of cardiovascular events in patients with high cardiovascular risk and an treated systolic blood pressure less than 130 mm Hg. The finding that a diastolic blood pressure value between 70 and 80 mm Hg was an optimum target for this patient population merits further study.
引用
收藏
页数:13
相关论文
共 31 条
[1]   J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial† [J].
Bangalore, Sripal ;
Messerli, Franz H. ;
Wun, Chuan-Chuan ;
Zuckerman, Andrea L. ;
DeMicco, David ;
Kostis, John B. ;
LaRosa, John C. .
EUROPEAN HEART JOURNAL, 2010, 31 (23) :2897-2908
[2]   Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control [J].
Beddhu, Srinivasan ;
Chertow, Glenn M. ;
Cheung, Alfred K. ;
Cushman, William C. ;
Rahman, Mahboob ;
Greene, Tom ;
Wei, Guo ;
Campbell, Ruth C. ;
Conroy, Margaret ;
Freedman, Barry I. ;
Haley, William ;
Horwitz, Edward ;
Kitzman, Dalane ;
Lash, James ;
Papademetriou, Vasilios ;
Pisoni, Roberto ;
Riessen, Erik ;
Rosendorff, Clive ;
Watnick, Suzanne G. ;
Whittle, Jeffrey ;
Whelton, Paul K. .
CIRCULATION, 2018, 137 (02) :134-143
[3]   Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk [J].
Bergmark, Brian A. ;
Scirica, Benjamin M. ;
Steg, Ph. Gabriel ;
Fanola, Christina L. ;
Gurmu, Yared ;
Mosenzon, Ofri ;
Cahn, Avivit ;
Raz, Itamar ;
Bhatt, Deepak L. .
EUROPEAN HEART JOURNAL, 2018, 39 (24) :2255-2262
[4]   Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial [J].
Boehm, Michael ;
Ferreira, Joao Pedro ;
Mahfoud, Felix ;
Duarte, Kevin ;
Pitt, Bertram ;
Zannad, Faiez ;
Rossignol, Patrick .
EUROPEAN HEART JOURNAL, 2020, 41 (17) :1673-1683
[5]   Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials [J].
Boehm, Michael ;
Schumacher, Helmut ;
Teo, Koon K. ;
Lonn, Eva ;
Mahfoud, Felix ;
Mann, Johannes F. E. ;
Mancia, Giuseppe ;
Redon, Josep ;
Schmieder, Roland ;
Weber, Michael ;
Sliwa, Karen ;
Williams, Bryan ;
Yusuf, Salim .
EUROPEAN HEART JOURNAL, 2018, 39 (33) :3105-3114
[6]   Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials [J].
Boehm, Michael ;
Schumacher, Helmut ;
Teo, Koon K. ;
Lonn, Eva M. ;
Mahfoud, Felix ;
Mann, Johannes F. E. ;
Mancia, Giuseppe ;
Redon, Josep ;
Schmieder, Roland E. ;
Sliwa, Karen ;
Weber, Michael A. ;
Williams, Bryan ;
Yusuf, Salim .
LANCET, 2017, 389 (10085) :2226-2237
[7]  
CRUICKSHANK JM, 1987, LANCET, V1, P581
[8]   Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus [J].
Cushman, William C. ;
Evans, Gregory W. ;
Byington, Robert P. ;
Goff, David C., Jr. ;
Grimm, Richard H., Jr. ;
Cutler, Jeffrey A. ;
Simons-Morton, Denise G. ;
Basile, Jan N. ;
Corson, Marshall A. ;
Probstfield, Jeffrey L. ;
Katz, Lois ;
Peterson, Kevin A. ;
Friedewald, William T. ;
Buse, John B. ;
Bigger, J. Thomas ;
Gerstein, Hertzel C. ;
Ismail-Beigi, Faramarz .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (17) :1575-1585
[9]   Diastolic blood pressure and risk profile in renal and cardiovascular diseases. Results from the SPRINT trial [J].
Del Pinto, Rita ;
Pietropaoli, Davide ;
Ferri, Claudio .
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2018, 12 (07) :513-523
[10]   Regulation of coronary blood flow during exercise [J].
Duncker, Dirk J. ;
Bache, Robert J. .
PHYSIOLOGICAL REVIEWS, 2008, 88 (03) :1009-1086